Title : Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning - Saifina_2022_Eur.J.Med.Chem_246_114949 |
Author(s) : Saifina LF , Abdalla M , Gubaidullina LM , Zueva IV , Eltayb WA , El-Arabey AA , Kharlamova AD , Lenina OA , Semenov VE , Petrov KA |
Ref : Eur Journal of Medicinal Chemistry , 246 :114949 , 2022 |
Abstract : Saifina_2022_Eur.J.Med.Chem_246_114949 |
ESTHER : Saifina_2022_Eur.J.Med.Chem_246_114949 |
PubMedSearch : Saifina_2022_Eur.J.Med.Chem_246_114949 |
PubMedID: 36462442 |
Saifina LF, Abdalla M, Gubaidullina LM, Zueva IV, Eltayb WA, El-Arabey AA, Kharlamova AD, Lenina OA, Semenov VE, Petrov KA (2022)
Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning
Eur Journal of Medicinal Chemistry
246 :114949
Saifina LF, Abdalla M, Gubaidullina LM, Zueva IV, Eltayb WA, El-Arabey AA, Kharlamova AD, Lenina OA, Semenov VE, Petrov KA (2022)
Eur Journal of Medicinal Chemistry
246 :114949